Recipharm recognised for its commitment to its operations in France

Contract development and manufacturing organisation (CDMO), Recipharm, has been awarded with ‘le Prix d’Excellence 2017 — Spécial Sciences de la vie’ by the Swedish Chamber of Commerce in France in recognition of its commitment to its French operations.

This award acknowledges examples of best practice in the Franco-Swedish business community. As a part of its application, Recipharm was assessed on its commercial success, profitability, technological innovation, quality and continued commitment to its operations in France.

“We established our French operations 10 years ago to cater for demand in Europe and offer easy market access to our customers. Since then we have acquired four sites and made substantial investments into our facilities, including an €18 million investment in 2016 into our blow-fill seal capability in Kaysersberg to meet customer demand in the US, Turkey, Australia and Canada,” stated Jean-François Hilaire, executive vice president Strategy and Global Integration at Recipharm.

“Our French facilities now serve over 50 of our customers worldwide, including a number of top 20 pharma firms, and employ over 20% of our staff,” he continued. “We have ongoing plans to grow our operations in the country and hope to see this positive trajectory continue for many years to come.”

Thomas Eldered, CEO at Recipharm added: “I am honoured that Recipharm has been acknowledged for our decade-long commitment to France. We have been very pleased with the development of our business there and I would like to thank the Swedish Chamber of Commerce in France for recognising this.”